Natalizumab and PML

Nature Neuroscience

Volumn 8, Issue 10, 2005, Pages 1275-

  Ransohoff, Richard M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NATALIZUMAB;

B LYMPHOCYTE; BONE MARROW; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CROHN DISEASE; DRUG MECHANISM; DRUG TARGETING; EPITHELIUM CELL; GLIA; HEMATOPOIETIC CELL; HUMAN; IMMUNOSURVEILLANCE; INFLAMMATION; INFLAMMATORY DISEASE; LETTER; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; T LYMPHOCYTE; VIRUS REPLICATION;

ANTIBODIES, MONOCLONAL; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL;

EID: 27744500993     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn1005-1275     Document Type: Letter

References (10)

1. Nat. Neurosci. 8, 837 (2005).
2. Berger, J.R. & Koralnik, I.J. N. Engl. J. Med. 353, 414-416 (2005).
3. Steinman, L. Nat. Rev. Drug Discov. 4, 510-518 (2005).
4. Arroyo, A.G., Yang, J.T., Rayburn, H. & Hynes, R.O. Cell 85, 997-1008 (1996).
5. Scott, L.M., Priestley, G.V. & Papayannopoulou, T. Mol. Cell. Biol. 23, 9349-9360 (2003).
6. Houff, S.A. et al. N. Engl. J. Med. 318, 301-305 (1988).
7. Jensen, P.N. & Major, E.O. J. Leukoc. Biol. 65, 428-438 (1999).
8. Van Assche, G. et al. N. Engl. J. Med. 353, 362-368 (2005).
9. Ransohoff, R.M., Kivisakk, P. & Kidd, G. Nat. Rev. Immunol. 3, 569-581 (2003).
10. Sheridan, C. Nat. Rev. Drug Discov. 4, 357-358 (2005).